Toronto Dominion Bank’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,380
| Closed | -$183K | – | 2207 |
|
|
2021
Q3 | $183K | Sell |
10,380
-1,439
| -12% | -$16.8K | ﹤0.01% | 1084 |
|
|
2021
Q2 | $114K | Buy |
11,819
+1,676
| +17% | +$15.8K | ﹤0.01% | 1113 |
|
|
2021
Q1 | $109K | Buy |
10,143
+3,165
| +45% | +$39.1K | ﹤0.01% | 1140 |
|
|
2020
Q4 | $102K | Buy |
6,978
+6,478
| +1,296% | +$93.4K | ﹤0.01% | 1090 |
|
|
2020
Q3 | $7K | Sell |
500
-184
| -27% | -$1.83K | ﹤0.01% | 1110 |
|
|
2020
Q2 | $5K | Buy |
684
+163
| +31% | +$1.01K | ﹤0.01% | 1146 |
|
|
2020
Q1 | $2K | Buy |
521
+13
| +3% | +$49 | ﹤0.01% | 1178 |
|
|
2019
Q4 | $1K | Sell |
508
-187
| -27% | -$72 | ﹤0.01% | 1326 |
|
|
2019
Q3 | $0 | Buy |
695
+551
| +383% | +$186 | ﹤0.01% | 1749 |
|
|
2019
Q2 | $0 | Sell |
144
-86
| -37% | -$44 | ﹤0.01% | 1850 |
|
|
2019
Q1 | $0 | Buy |
+230
| New | +$281 | ﹤0.01% | 1807 |
|
|
2018
Q4 | – | Sell |
-22
| Closed | – | – | 1716 |
|
|
2018
Q3 | $0 | Buy |
22
+6
| +38% | +$34 | ﹤0.01% | 1644 |
|
|
2018
Q2 | $0 | Sell |
16
-71
| -82% | -$453 | ﹤0.01% | 1612 |
|
|
2018
Q1 | $1K | Buy |
87
+31
| +55% | +$235 | ﹤0.01% | 1282 |
|
|
2017
Q4 | $0 | Buy |
+56
| New | +$464 | ﹤0.01% | 1339 |
|
|
2017
Q3 | – | Sell |
-12
| Closed | – | – | 1273 |
|
|
2017
Q2 | $0 | Buy |
+12
| New | +$66 | ﹤0.01% | 1315 |
|
|
2016
Q4 | – | Sell |
-63
| Closed | -$1K | – | 1339 |
|
|
2016
Q3 | $1K | Buy |
63
+13
| +26% | +$150 | ﹤0.01% | 1185 |
|
|
2016
Q2 | $0 | Buy |
+50
| New | +$520 | ﹤0.01% | 1330 |
|
|
2016
Q1 | – | Sell |
-38
| Closed | – | – | 1317 |
|
|
2015
Q4 | $0 | Sell |
38
-6
| -14% | -$83 | ﹤0.01% | 1121 |
|
|
2015
Q3 | $1K | Sell |
44
-71
| -62% | -$1.3K | ﹤0.01% | 1031 |
|
|
2015
Q2 | $2K | Buy |
+115
| New | +$2.62K | ﹤0.01% | 1065 |
|
|
2015
Q1 | – | Sell |
-6
| Closed | – | – | 1115 |
|
|
2014
Q4 | $0 | Buy |
+6
| New | +$47 | ﹤0.01% | 1087 |
|
Other funds holding TRIL
Toronto Dominion Bank's TRIL Position: Q4 2021 in Review
Toronto Dominion Bank sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,380 shares — an estimated $183K sold.
Toronto Dominion Bank first reported a position in TRIL in Q4 2014 and held it in 22 quarters. The position peaked at $183K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.
- Toronto Dominion Bank reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
- Toronto Dominion Bank sold 10,380 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $183K.
- Toronto Dominion Bank first reported a position in Trillium Therapeutics Inc. in Q4 2014 and held it in 22 quarters.
- Toronto Dominion Bank's Trillium Therapeutics Inc. position peaked at $183K in Q3 2021.
- 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.
Based on Toronto Dominion Bank's 13F filing for Q4 2021, filed 4 Feb 2022.